Time-dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 86, Issue 13, 2008, Pages 2992-3001

  Das, Arabinda ^a   Guyton, M Kelly ^a   Matzelle, Denise D ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acute EAE; Calpain; Neuronal apoptosis; Spinal cord

Indexed keywords

CALCINEURIN; CALPAIN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; GENOMIC DNA; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEINASE;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; LEWIS RAT; MALE; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD NERVE CELL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALPAIN; CASPASES; DNA FRAGMENTATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; NECROSIS; NERVE DEGENERATION; NEURONS; RATS; RATS, INBRED LEW; SPINAL CORD; TIME;

EID: 57049142576     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21737     Document Type: Article

References (44)

1. Bauer J, Stadelmann C, Bancher C, Jellinger K, Lassmann H. 1999. Apoptosis of T lymphocytes in acute disseminated encephalomyelitis. Acta Neuropathol (Berl) 97:543-546.
2. Bechtold DA, Kapoor R, Smith KJ. 2004. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 55:607-616.
3. Benveniste EN. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75:165-173.
4. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W. 2000. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123:1174-1183.
5. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C, Hagberg H. 2001. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 276:10191-10198.
6. Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, Song SK. 2007. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed [Epub ahead of print].
7. Choi WS, Lee EH, Chung CW, Jung YK, Jin BK, Kim SU, Oh TH, Saido TC, Oh YJ. 2001. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 77:1531-1541.
8. Das A, Banik NL, Ray SK. 2007. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-γ and taxol for apoptosis. Neurochem Res 32:2167-2183.
9. 2+ influx. Brain Res 1084:146-157.
10. Das A, Sribnick EA, Wingrave JM, Del Re AM, Woodward JJ, Appel SH, Banik NL, Ray SK. 2005. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res 81:551-562.
11. Deshpande RV, Goust JM, Hogan EL, Banik NL. 1995. Calpain secreted by activated human lymphoid cells degrades myelin. J Neurosci Res 42:259-265.
12. Gores GJ, Miyoshi H, Botla R, Aguilar HI, Bronk SF. 1998. Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases. Biochim Biophys Acta 1366:167-175.
13. Guyton MK, Sribnick EA, Ray SK, Banik NL. 2005a. A role for calpain in optic neuritis. Ann N Y Acad Sci 1053:48-54.
14. Guyton MK, Wingrave JM, Yallapragada AV, Wilford GG, Sribnick EA, Matzelle DD, Tyor WR, Ray SK, Banik NL. 2005b. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res 81:53-61.
15. Hassen GW, Feliberti J, Kesner L, Stracher A, Mokhtarian F. 2006. A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis. J Neuroimmunol. 180:135-146.
16. Hinman JD, Duce JA, Siman RA, Hollander W, Abraham CR. 2004. Activation of calpain-1 in myelin and microglia in the white matter of the aged Rhesus monkey. J Neurochem 89:430-441.
17. Imam SA, Guyton MK, Haque A, Vandenbark A, Tyor WR, Ray SK, Banik NL. 2007. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol 190:139-145.
18. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53:285-302.
19. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK. 2006. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21:626-632.
20. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
21. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W. 2002. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202-2212.
22. Lankiewicz S, Marc Luetjens C, Truc Bui N, Krohn AJ, Poppe M, Cole GM, Saido TC, Prehn JH. 2000. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J Biol Chem 275:17064-17071.
23. Li H, Zhu H, Xu CJ, Yuan J. 1998. Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis, Cell 94:491-501.
24. Martin R, McFarland HF. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121-182.
25. Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D. 1994. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis. J Immunol 152:6003-6010.
26. Nakagawa T, Yuan J. 2000. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150:887-894.
27. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB, Wang KK, 1996. Non-erythroid α-spectrin breakdown by calpain and interleukin-1β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis, Biochem J 319:683-690.
28. Neumar RW, Xu YA, Gada H, Guttmann RP, Siman R. 2003. Crosstalk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem 278:14162-14167.
29. Ray SK, Matzelle DC, Wilford GG, Hogan EL, Banik NL. 2000. E-64-d prevents both calpain up-regulation and apoptosis in the lesion and penumbra following spinal cord injury in rats. Brain Res 867:80-89.
30. Ray SK, Shields DC, Saido TC, Matzelle DC, Wilford GG, Hogan EL, Banik NL. 1999. Calpain activity and translational expression increased in spinal cord injury. Brain Res 816:375-380.
31. Ray SK, Banik NL. 2003. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2:173-189.
32. Schaecher K, Rocchini A, Dinkins J, Matzelle DD, Banik NL. 2002. Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease. J Neuroimmunol 129:1-9.
33. Shields DC, Banik NL. 1998. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination. Brain Res 794:68-74.
34. Shields DC, Banik NL. 1999. Pathophysiological role of calpain in experimental demyelination. J Neurosci Res 55:533-541.
35. Shields DC, Schaecher KE, Goust JM, Banik NL. 1999a. Calpain activity and expression are increased in splenic inflammatory cells associated with experimental allergic encephalomyelitis. J Neuroimmunol 99:1-12.
36. Shields DC, Schaecher KE, Saido TC, Banik NL. 1999b. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci U S A 96:11486-11491.
37. Sloane JA, Hinman JD, Lubonia M, Hollander W, Abraham CR. 2003. Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the Rhesus monkey. J Neurochem 84:157-168.
38. Sospedra M, Martin R. 2005. Antigen-specific therapies in multiple sclerosis. Int Rev Immunol 24:393-413.
39. Varghese J, Radhika G, Sarin A. 2001. The role of calpain in caspase activation during etoposide induced apoptosis in T cells. Eur J Immunol 31:2035-2041.
40. 2+-induced apoptosis through calcineurin dephosphorylation of Bad. Science 284:339-343.
41. Wang KK, Posmantur R, Nath R, McGinnis K, Whitton M, Talanian RV, Glantz SB, Morrow JS. 1998a. Simultaneous degradation of αII-and ΙI-spectrin by caspase-3 (CPP32) in apoptotic cells. J Biol Chem 273:22490-22497.
42. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L, Allen H. 1998b. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 356:187-196.
43. Yamashima T. 2000. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62:273-295.
44. Zhang SX, Bondada V, Geddes JW. 2003. Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection. J Neurotrauma 20:59-67.